Single inhaler triple therapy in advanced COPD patients: prior medication and disease severity FULFIL subanalyses

D. Lipson (Wynnewood, United States of America)

Source: International Congress 2017 – COPD management
Session: COPD management
Session type: Thematic Poster
Number: 1057
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Lipson (Wynnewood, United States of America). Single inhaler triple therapy in advanced COPD patients: prior medication and disease severity FULFIL subanalyses. 1057

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Single inhaler triple therapy in patients with advanced COPD (FULFIL): exacerbation/pneumonia composite outcomes
Source: International Congress 2017 – COPD management
Year: 2017


Clinically important deterioration in advanced COPD patients using single inhaler triple therapy: results from the FULFIL study
Source: International Congress 2017 – Management of COPD
Year: 2017


Are COPD patients taking triple combination inhalers being overmedicated during acute exacerbations?
Source: International Congress 2019 – COPD treatment: cohorts and real-world studies
Year: 2019


Effect of ICS withdrawal on COPD exacerbations in patients on triple therapy at baseline
Source: International Congress 2018 – COPD management
Year: 2018


Comparative effectiveness of two different doses of inhaled corticosteroid in triple therapy on exacerbations in patients with severe COPD: a real-world study
Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19
Year: 2021


Extrafine triple therapy in patients with symptomatic COPD and history of one moderate exacerbation
Source: Eur Respir J, 53 (5) 1900235; 10.1183/13993003.00235-2019
Year: 2019



Improvement in health status in patients with moderate to severe COPD after treatment with budesonide/formoterol in a single inhaler
Source: Eur Respir J 2002; 20: Suppl. 38, 250s
Year: 2002

Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analyses
Source: ERJ Open Res, 4 (2) 00119-2017; 10.1183/23120541.00119-2017
Year: 2018



Treatment patterns in English asthma patients initiating multiple inhaler triple therapy: a cohort study
Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights
Year: 2020


Single inhaler triple therapy in patients with COPD: patient-reported dyspnoea and health status from the IMPACT Trial
Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet?
Year: 2018




Evaluation of adherence of patients with asthma to treatment by single combination inhaler
Source: Eur Respir J 2006; 28: Suppl. 50, 499s
Year: 2006

Influence of statin therapy on exacerbation frequency in patients with COPD
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009

Symptomatic burden of COPD for patients receiving dual or triple therapy
Source: International Congress 2017 – Management of COPD
Year: 2017


Triple therapy de-escalation to dual bronchodilation in COPD patients: Baseline data from the DACCORD cohort
Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more
Year: 2020


LATE-BREAKING ABSTRACT: Single inhaler triple therapy (ICS/LAMA/LABA) in patients with advanced COPD: Results of the FULFIL trial
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016


Osteoporosis risk assessment in elderly male patients with COPD who use inhaled corticosteroids
Source: Annual Congress 2006 - COPD therapy
Year: 2006


Efficacy of a combination therapy with single inhaler budesonide/formoterol in the treatment of acute exacerbations of COPD (AECOPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 252s
Year: 2004

Exacerbation frequency and eosinophil levels for GOLD C and D COPD patients currently prescribed multiple inhaler triple therapy (MITT)
Source: International Congress 2018 – Epidemiology of asthma, COPD and factors that associate with lung function
Year: 2018


Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015


Influence of treatment by single combined inhaler on adherence of patients with asthma
Source: Annual Congress 2009 - Respiratory physiology
Year: 2009